Lyzat bacteria | Broncho-munal capsules 7 mg, 30 pcs.
Special Price
$40.18
Regular Price
$48.00
In stock
SKU
BID464447
Latin name
BRONCHO-MUNAL
BRONCHO-MUNAL
Latin name
BRONCHO-MUNAL
Release form
Hard gelatin capsules, size No. 3, opaque, with a body and a lid of blue color capsule contents - light beige powder.
packaging 10 pcs - blisters (3) - packs of cardboard.
Pharmacological action
Immunomodulating drug of bacterial origin.
Stimulates both the local cellular and humoral immune responses in the mucous membrane of the airways and the systemic immune response.
The drug stimulates the activity of alveolar macrophages, increases the number and activity of T-lymphocytes, activates peripheral monocytes, increases the concentration of secretory IgA on the mucous membranes of the respiratory tract and digestive tract, stimulates the production of protective adhesive molecules, reduces the concentration of IgE antibodies in the blood, and also increases the production of cytokines.
Reduces the frequency and severity of infections, thereby reducing the need for antibiotics.
Indications
infectious diseases of the respiratory tract (as part of complex therapy as an immunomodulating agent) in children aged 6 months to 12 years (for capsules 3. 5 mg)
infectious respiratory diseases (as part of complex therapy as an immunomodulating agent) in adults and children over 12 years of age (for 7 mg capsules)
for the prevention of recurrent infections of the upper and lower respiratory tract (chronic bronchitis, tonsillitis, pharyngitis, laryngitis, rhinitis, sinusitis, otitis media).
Contraindications
Increased individual sensitivity to the components of the drug.
Use during pregnancy and lactation
The use of the drug Broncho-munalВ® during pregnancy and lactation is possible only if the intended benefit to the mother outweighs the potential risk to the fetus or baby.
Composition
1 caps.
lyophilized bacterial lysate: Streptococcus pneumoniae, Haemophilus influenzae, Klebsiella pneumoniae, Klebsiella ozaenae, Staphylococcus aureus, Streptococcus viridans, Streptococcus pyogenes, Moraxella catarrhalis 7 mg
Excipients:
propyl gallate (anhydrous),
gelatin.
Side effects of
During the entire period of the clinical use of the drug, unwanted effects were extremely rare.
In some cases: digestive system disorders (epigastric pain, nausea, vomiting, diarrhea), fever.
If side effects are mild, discontinuation of the drug is not required. When a hypersensitivity reaction occurs, drug withdrawal is recommended.
Drug Interaction
The drug can be used at the same time as other medicines, including antibiotics.
Overdose
No clinical symptoms of overdose were noted.
There are no reports of intoxication due to drug overdose.
Storage conditions
The drug should be stored out of the reach of children at a temperature of 15 ° to 25 РC.
Expiration
5 years.
Conditions of supply of pharmacies without prescription
Formulation
Dosage form
capsules
BRONCHO-MUNAL
Release form
Hard gelatin capsules, size No. 3, opaque, with a body and a lid of blue color capsule contents - light beige powder.
packaging 10 pcs - blisters (3) - packs of cardboard.
Pharmacological action
Immunomodulating drug of bacterial origin.
Stimulates both the local cellular and humoral immune responses in the mucous membrane of the airways and the systemic immune response.
The drug stimulates the activity of alveolar macrophages, increases the number and activity of T-lymphocytes, activates peripheral monocytes, increases the concentration of secretory IgA on the mucous membranes of the respiratory tract and digestive tract, stimulates the production of protective adhesive molecules, reduces the concentration of IgE antibodies in the blood, and also increases the production of cytokines.
Reduces the frequency and severity of infections, thereby reducing the need for antibiotics.
Indications
infectious diseases of the respiratory tract (as part of complex therapy as an immunomodulating agent) in children aged 6 months to 12 years (for capsules 3. 5 mg)
infectious respiratory diseases (as part of complex therapy as an immunomodulating agent) in adults and children over 12 years of age (for 7 mg capsules)
for the prevention of recurrent infections of the upper and lower respiratory tract (chronic bronchitis, tonsillitis, pharyngitis, laryngitis, rhinitis, sinusitis, otitis media).
Contraindications
Increased individual sensitivity to the components of the drug.
Use during pregnancy and lactation
The use of the drug Broncho-munalВ® during pregnancy and lactation is possible only if the intended benefit to the mother outweighs the potential risk to the fetus or baby.
Composition
1 caps.
lyophilized bacterial lysate: Streptococcus pneumoniae, Haemophilus influenzae, Klebsiella pneumoniae, Klebsiella ozaenae, Staphylococcus aureus, Streptococcus viridans, Streptococcus pyogenes, Moraxella catarrhalis 7 mg
Excipients:
propyl gallate (anhydrous),
gelatin.
Side effects of
During the entire period of the clinical use of the drug, unwanted effects were extremely rare.
In some cases: digestive system disorders (epigastric pain, nausea, vomiting, diarrhea), fever.
If side effects are mild, discontinuation of the drug is not required. When a hypersensitivity reaction occurs, drug withdrawal is recommended.
Drug Interaction
The drug can be used at the same time as other medicines, including antibiotics.
Overdose
No clinical symptoms of overdose were noted.
There are no reports of intoxication due to drug overdose.
Storage conditions
The drug should be stored out of the reach of children at a temperature of 15 ° to 25 РC.
Expiration
5 years.
Conditions of supply of pharmacies without prescription
Formulation
Dosage form
capsules
Write Your Own Review